The expression of CCR4 on TH2 cells has prompted some interest in it as a therapeutic target for asthma and other allergic diseases as the cytokines produced by these cells (interleukins 4, 5, 9, and 13) are thought to induce the pathological changes associated with these diseases (Larche et al. 2003). This evidence concerns the gene CCR4 and allergic disease.